Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - COHEN FRED E
Last Updated 
6-Sep-16
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

COHEN FRED E: Declared Holdings
Company/RelationshipReportedShares  Ownership
BioCryst Pharmaceuticals, Inc.
Director
NasdaqGS:BCRX
(historical quotes, profile, SEC, other insiders)
1-Sep-16114,079  Direct
CareDx, Inc.
Director
NasdaqGM:CDNA
(historical quotes, profile, other insiders)
15-Jul-1616,596  Direct
Five Prime Therapeutics, Inc.
Director
NasdaqGS:FPRX
(historical quotes, profile, other insiders)
11-Jan-1624,807  Direct
Genomic Health, Inc.
Director
NasdaqGS:GHDX
(historical quotes, profile, other insiders)
1-Jul-1664,893  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
1-Sep-16 2,433BCRX Acquisition (Non Open Market) at $4.11 per share.
(Value of $9,999)
15-Jul-16 5,000CDNA Acquisition (Non Open Market) at $0 per share.
1-Jul-16 373GHDX Acquisition (Non Open Market) at $26.74 per share.
(Value of $9,974)
1-Jul-16 2,695CDNA Acquisition (Non Open Market) at $0 per share.
31-May-16 2,581BCRX Acquisition (Non Open Market) at $3.39 per share.
(Value of $8,749)
1-Apr-16 1,954CDNA Acquisition (Non Open Market) at $0 per share.
1-Apr-16 392GHDX Acquisition (Non Open Market) at $25.48 per share.
(Value of $9,988)
29-Feb-16 4,396BCRX Acquisition (Non Open Market) at $1.99 per share.
(Value of $8,748)
11-Jan-16 24,695FPRX Option Exercise at $5.54 - $12.7 per share.
1-Jan-16 1,836CDNA Acquisition (Non Open Market) at $0 per share.
1-Jan-16 284GHDX Acquisition (Non Open Market) at $35.20 - $35.2 per share.
(Value of about $9,996)
30-Nov-15 824BCRX Acquisition (Non Open Market) at $10.61 - $10.61 per share.
(Value of about $8,742)
1-Oct-15 468GHDX Acquisition (Non Open Market) at $21.34 - $21.34 per share.
(Value of about $9,987)
1-Oct-15 1,008CDNA Acquisition (Non Open Market) at $0 per share.
31-Aug-15 751BCRX Acquisition (Non Open Market) at $11.64 - $11.64 per share.
(Value of about $8,741)
1-Jul-15 365GHDX Acquisition (Non Open Market) at $27.34 - $27.34 per share.
(Value of about $9,979)
1-Jul-15 1,227CDNA Acquisition (Non Open Market) at $0 per share.
29-May-15 780BCRX Acquisition (Non Open Market) at $11.21 - $11.21 per share.
(Value of about $8,743)
1-Apr-15 1,075CDNA Acquisition (Non Open Market) at $0 per share.
1-Apr-15 328GHDX Acquisition (Non Open Market) at $30.43 - $30.43 per share.
(Value of about $9,981)
27-Feb-15 857BCRX Acquisition (Non Open Market) at $10.20 - $10.2 per share.
(Value of about $8,741)
8-Jan-15 100,000BCRX Option Exercise at $1.29 - $1.29 per share.
(Cost of about $129,000)
1-Jan-15 312GHDX Acquisition (Non Open Market) at $31.97 - $31.97 per share.
(Value of about $9,974)
1-Jan-15 1,143CDNA Acquisition (Non Open Market) at $0 per share.
28-Nov-14 809BCRX Acquisition (Non Open Market) at $10.81 - $10.81 per share.
(Value of about $8,745)
1-Oct-14 350GHDX Acquisition (Non Open Market) at $28.54 - $28.54 per share.
(Value of about $9,989)
1-Oct-14 658CDNA Acquisition (Non Open Market) at $0 per share.


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?